FOR IMMEDIATE RELEASE March 12, 2018 kim.treanor@keionline.org (202)-332-2670 A coalition of 16 advocacy organizations in the United States and Korea asked trade negotiators in the U.S. and Korea to reject the demands of the pharmaceutical industry, protect human rights, and… Continue Reading
In a resolution dated the 9th of March, 2018, Minister Carmen Castillo Taucher of Chile’s Ministry of Health has announced that there are sufficient public health reasons to support a compulsory license on medicines for the hepatitis C virus (HCV),… Continue Reading
On Tuesday, 6 March 2018, Cristina Pucarinho, the Deputy Permanent Representative of Portugal to the United Nations made the following intervention at a UN briefing on Promoting Innovation and Access to Health Technologies in the Context of the Agenda 2030… Continue Reading
There is a specialized web page on delinkage here: http://delinkage.org De-linkage can be defined in the negative, by saying that the R&D funding should not be tied to the price of the product. Progressive de-linkage means that governments implement reforms… Continue Reading
Cases 2017 Kaneka Corp. v. SKC Kolon PI, Inc., No. EDCV113397JGBRZX, 2017 WL 6343537 (C.D. Cal. Dec 8, 2017). Infringement case involving patents for polyimide films; motion for permanent injunction denied. Amgen Inc. v. Sanofi, 872 F.3d 1367 (Fed. Cir.… Continue Reading
World Health Assembly, May 2001 Statements May 21, 2001. Health GAP Report on the 54th World Health Assembly. May 18, 2001. CPT/Essential Action Comments on the World Health Assembly. May 17, 2001. HealthGAP Coalition Release on the World Health Assembly.… Continue Reading
Bayh-Dole cases involving royalty free or march-in rights 1997 Cellpro case This was a strong case involving two competing medical devices, both invented on NIH grants, and a bad ending. The NIH rejection of the Cellpro march-in request led to… Continue Reading
(More on this topic here: https://www.keionline.org/orphan-drugs and here.) 1980 April 17, 1980. Congresswoman Elizabeth Holtzman introduces H.R.7089 (96th Congress) – “A bill to establish an office in the National Institutes of Health to assist in the development of drugs for… Continue Reading
Representative Ro Khanna (D-CA-17) was joined by 17 other members of Congress in calling upon Department of Health and Human Services Secretary Alex Azar to issue a compulsory license on patents for medications to treat hepatitis C, by exercising 28… Continue Reading
2000 SPECIAL 301 REPORT United States Trade Representative Charlene Barshefsky today announced the results of the 2000 “Special 301” annual review which examined in detail the adequacy and effectiveness of intellectual property protection in over 70 countries. Ambassador Barshefsky also… Continue Reading